Search
Search Results
##search.searchResults.foundPlural##
-
APLASTIC ANEMIA AND VIRAL HEPATITIS
1304PDF: 539HTML: 23124 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2604PDF: 871HTML: 9052Efremov 1: 249Efremov 2: 211 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1120PDF: 1237HTML: 116 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7256PDF: 4046HTML: 24961 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2041PDF: 1328HTML: 792 -
Acquired Hemophilia A successfully treated with rituximab
2158PDF: 1176HTML: 1491Figure 1: 205 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3747PDF: 924HTML: 6861 -
How I treat acute and persistent sickle cell pain
2033PDF: 1144HTML: 648 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3382PDF: 1277HTML: 8386 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1827PDF: 568HTML: 16989Figure 4: 184Figure 3: 156Figure 2: 163Figure 1: 197 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1230PDF: 859HTML: 3413 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3772PDF: 1276HTML: 3917Untitled: 248Untitled: 282 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1439PDF: 892HTML: 230 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2600PDF: 966HTML: 556 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1424PDF: 940HTML: 421 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2753PDF: 975HTML: 621 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1651PDF: 834HTML: 1275Figure 1: 187Figure 2: 201Figure 3: 198 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2190PDF: 1590HTML: 650 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
878PDF: 493HTML: 1310 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4258PDF: 1976HTML: 5498Table 1: 226 -
-
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
1675PDF: 1018HTML: 376 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2977PDF: 1399HTML: 3719Untitled: 208Untitled: 221Untitled: 195 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6222PDF: 3418HTML: 9052Figure Malaria Ricci: 244 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1182PDF: 560HTML: 1703Figures: 183Fifures Sanz: 190tables Sanz: 192Untitled: 188







